Sunday, April 04, 2010 3:00:10 AM
ximon, with your PLBI excitement...
I too have been quietly sharing in your same excitement with PLBI (Proton Laboratories, Inc.) as their acquisition of Regenobody is huge in my opinion:
http://www.regenobody.com/
As previously mentioned, PLBI is a stem cells company that is partnered with RNL BIO through its Regenobody acquisition which is an extension of RNL’s licenses and procedures to say the least. New investors should see below:
Regenobody S.A. Obtains License From the Dominican Republic to Harvest, Incubate, and Transplant Stem Cells
http://www.globenewswire.com/news.html?d=181734
…Armando Casciati, President of Proton Laboratories, Inc., stated; "This is tremendous news for our company. Very rarely are companies licensed by their respective governments to conduct research, harvest, and incubate stems cells while then being able to transplant these cells back to the patients for therapeutic benefit." Regenobody S.A. will be utilizing procedures and equipment obtained through an EXCLUSIVE Caribbean license from its Korean licensor and patent holder, RNL BIO Co. Ltd. Prior to Regenobody S.A. obtaining the EXCLUSIVE Caribbean licensing rights, these procedures were only available in Japan, Korea, and China. …
I think investors still have no clue of this potential… yet. This is huge as RNL definitely has this kind of confidence in PLBI for some very powerful and yet thus far subliminal reasons or they would not have ever been involved with them in my opinion. Just the RNL BIO involvement with PLBI and at these levels should warrant for many more investors to take the risk as more investors are made known of PLBI. RNL BIO is a Multi-billion dollar company. Make that a greater than $28 billion company. Their website below speaks volumes:
http://rnl.co.kr/eng/main.asp
Stem cells treatment is a type of medical treatment that I think investors will learn more and more about as time goes on and how important it is to medicine. This is a very powerful video and quote in my opinion from the PLBI website below:
http://www.regenobody.com/therapy.htm
…”The treatment is not a cure, IT IS A PROCESS OF REPAIR, that occurs at varying levels.” …
The PLBI name, ticker, and cusip# changes are expected to transpire any day per one of their previous PRs. I expect that major announcements will commence soon after as I am sure that they would want to make sure any major announcements are made and listed under their new name, ticker, and cusip#.
v/r
Sterling
I too have been quietly sharing in your same excitement with PLBI (Proton Laboratories, Inc.) as their acquisition of Regenobody is huge in my opinion:
http://www.regenobody.com/
As previously mentioned, PLBI is a stem cells company that is partnered with RNL BIO through its Regenobody acquisition which is an extension of RNL’s licenses and procedures to say the least. New investors should see below:
Regenobody S.A. Obtains License From the Dominican Republic to Harvest, Incubate, and Transplant Stem Cells
http://www.globenewswire.com/news.html?d=181734
…Armando Casciati, President of Proton Laboratories, Inc., stated; "This is tremendous news for our company. Very rarely are companies licensed by their respective governments to conduct research, harvest, and incubate stems cells while then being able to transplant these cells back to the patients for therapeutic benefit." Regenobody S.A. will be utilizing procedures and equipment obtained through an EXCLUSIVE Caribbean license from its Korean licensor and patent holder, RNL BIO Co. Ltd. Prior to Regenobody S.A. obtaining the EXCLUSIVE Caribbean licensing rights, these procedures were only available in Japan, Korea, and China. …
I think investors still have no clue of this potential… yet. This is huge as RNL definitely has this kind of confidence in PLBI for some very powerful and yet thus far subliminal reasons or they would not have ever been involved with them in my opinion. Just the RNL BIO involvement with PLBI and at these levels should warrant for many more investors to take the risk as more investors are made known of PLBI. RNL BIO is a Multi-billion dollar company. Make that a greater than $28 billion company. Their website below speaks volumes:
http://rnl.co.kr/eng/main.asp
Stem cells treatment is a type of medical treatment that I think investors will learn more and more about as time goes on and how important it is to medicine. This is a very powerful video and quote in my opinion from the PLBI website below:
http://www.regenobody.com/therapy.htm
…”The treatment is not a cure, IT IS A PROCESS OF REPAIR, that occurs at varying levels.” …
The PLBI name, ticker, and cusip# changes are expected to transpire any day per one of their previous PRs. I expect that major announcements will commence soon after as I am sure that they would want to make sure any major announcements are made and listed under their new name, ticker, and cusip#.
v/r
Sterling
Sterling's Trading & Investing Strategies:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39092516
